Pandina, G., Kushner, S., Karcher, K., & Haas, M. (2012). An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia. BioMed Central.
Dyfyniad Arddull ChicagoPandina, Gahan, Stuart Kushner, Keith Karcher, and Magali Haas. An Open-label, Multicenter Evaluation of the Long-term Safety and Efficacy of Risperidone in Adolescents With Schizophrenia. BioMed Central, 2012.
Dyfyniad MLAPandina, Gahan, Stuart Kushner, Keith Karcher, and Magali Haas. An Open-label, Multicenter Evaluation of the Long-term Safety and Efficacy of Risperidone in Adolescents With Schizophrenia. BioMed Central, 2012.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.